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ABSTRACT 
Objective: To compare parascalene approach of brachial plexus block with the 
classical subclavian perivascular approach in patients undergoing upper limb  
surgeries using nerve stimulator 
   
Materials and methods: Sixty patients (age 20 - 50 years) undergoing upper limb  
surgeries were randomly assigned to two groups, Group A (n=30) receiving  
brachial plexus block using subclavian perivascular approach and Group B (n=30)  
receiving brachial plexus block using parascalene approach. Insulated needles and  
a nerve stimulator were used with both  techniques. Time required  for  
performing the block, onset of sensory and motor block, sensory block to pin prick,  
success rate, complications and rescue analgesia requirement were compared. 
Results: Time required for performing the block (4.7±0.92 min vs.2.9 ±0.84 min )  
were significantly shorter and  sensory block level to pinprick is higher (shoulder  
level), the overall success rates were high, complications and rescue analgesia 
 requirement are low in Group B as compared to Group A.  
Conclusion: Supraclavicular block of brachial plexus by Parascalene approach  
provides an adequate sensory blockade and motor blockade, with less time to 
 perform block, level of sensory block is higher ( upto shoulder ), high success rate  
and less complications when compared to subclavian perivascular approach. 
 
Key words: Regional anaesthesia, brachial plexus block, parascalene approach, 
subclavian perivascular approach, local anaesthetics, nerve stimulator 
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INTRODUCTION 
Regional anaesthesia is the anaesthesia of an anatomic part 
produced by the application of a chemical capable of blocking conduction 
in nerve tissue associated with the part, there by one region of the body is 
made insensitive to pain in response to surgical stimuli35. The agent must 
not damage the tissue permanently and the functional derangement must 
be reversible. The higher centres of brain are spared, so that the patient is 
conscious during the surgical procedure.  
Regional anaesthesia has many advantages over general 
anaesthesia for upper limb surgeries, especially in emergency surgeries. 
Advantages of regional over general anaesthesia: 
 Proven to be safe for high risk patients who are otherwise in 
greater risk due to the stress imposed by general anaesthesia. 
 Safest technique for patients with full stomach. 
 It is cost effective and safe. 
 All the adverse effects of airway manipulation can be avoided 
 Many intraoperative and postoperative complications of general 
anaesthesia can be avoided. 
 Avoids theatre pollution 
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 Only method of anaesthesia, which prevent all afferent impulses 
from the site of surgery from reaching the central nervous system. 
Hence the need for poly pharmacy is eliminated. 
 Causes least physiological disturbances when compared to general 
anaesthesia 
 Along with complete pain relief and total muscle relaxation it 
produces vasodilatation, which improves blood circulation, 
prevents tissue hypoxia and blood loss. 
 Postoperative pain relief is ensured for a longer duration by using 
long acting anaesthetic drug and for several days if a continuous 
block using  catheter technique is employed. 
Blockade of brachial plexus is a useful regional anaesthesia for 
upper limb surgeries.There are different approaches but the ones 
frequently employed for blocking of brachial plexus2 include 
1. Interscalene approach 
2. Supraclavicular approach 
3. Infraclavicular approach and 
4. Axillary approach 
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HISTORY 
William Steward Halsted first performed brachial plexus block in 
1885. In 1911, Kulenkampff and Hirshel described the first percutaneous 
brachial plexus block by supraclavicular and axillary routes respectively. 
Continuous brachial plexus block technique was first described by F. Paul 
Ansbro in 1946. 
Since then many approaches of brachial plexus block have been 
tried to increase the rate of success and reducing the risk and 
complications. Among the various techniques the most widely practiced 
methods are  
1. The classical technique described by Patric (1940) 
2. Vertical Plumb Bob approach described by Brown  
3. 1st rib walk over technique described by Bonica and Moore 
4. Classical Subclavian perivascular approach described by Winnie 
and Collins in 1964 
5. Parascalene approach by Vongvises, P and Panijayanond in 1979 
6. Raj and Sims described an infraclavicular approach using 
peripheral nerve stimulator in 1973 and 1977 respectively.  
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BRACHIAL PLEXUS BLOCK APPROACHES 
INTERSCALENE APPROACH :   
Root level blockade 
ADVANTAGES: 
 This is ideal for shoulder surgery 
 Cervical plexus can also be blocked by this method 
 Clear landmarks appreciated 
 Lower volume sufficient for block 
 Lesser chance of pneumothorax than in  supraclavicular block 
DISADVANTAGES: 
 An unreliable block for forearm and hand surgeries as there is 
inadequate anaesthesia in the ulnar nerve  distribution 
 Supplemental block necessary for blocking intercostobrachial 
nerve 
 May also block phrenic nerve, vagus, recurrent laryngeal nerve and 
cervical sympathetic nerves. 
 Inadvertent entry of drug to the epidural and subarachnoid space 
may produce dangerously high epidural, subdural, spinal 
anaesthesia. 
 Intra vascular injection into vertebral artery may also occur. 
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SUPRACLAVICULAR APPROACH :  
Block done at the trunk level  
ADVANTAGES: 
 Most compactly arranged form of nerve fibres – High success rate 
 Most intensive blockade achieved 
 Smaller volume being required 
 Quicker onset achieved 
 All of the nerves are being reliably blocked 
 Catheter can be inserted for prolonged procedures like hand 
transplant surgeries. 
Hence the supraclavicular approach is the method of choice for 
blocking the brachial plexus 
DISADVANTAGES: 
 Demonstrable paraesthesia (by the blind technique)  is unpleasant 
for the patient. 
 0.5 – 6% of pneumothorax  incidence seen 
INFRACLAVICULAR APPROACH :  
Block at the level of cords 
Disadvantages are the axilla and proximal medial arm skin are not 
anaesthetized (intercostobrachial and medium cutaneous brachii nerves 
6 
 
are spared), hemothorax, pneumo thorax, chylothorax are likely 
complications which may occur. 
AXILLARY APPROACH :  
ADVANTAGES: 
  Provides excellent anaesthesia for surgeries below the elbow. 
  Ease of performance, even in paediatric patients 
 Easily demonstrable landmarks. 
 Safest of all the techniques. 
 Paraesthesia here is not necessary 
  
DISADVANTAGES : 
 Inadequate anaesthesia of the radial aspect of forearm and dorsum 
of hand as there is sparing in the musculocutaneous nerve 
distribution. 
 Tourniquet pain is not well tolerated. 
 Also abducting the arm by 90 degrees for giving the block may be 
painful and even dangerous in traumatic lesions of the upper 
extremity. 
 Difficult to perform in obese individuals. 
 Hematoma formation. 
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Of the several local anaesthetic drugs, bupivacaine is the most 
commonly used drug in the regional block technique, mainly due to its 
long duration of action and common availability.  
 
To prolong the duration of anaesthesia, various drugs have been 
studied as adjuvant to the local anaesthetic solution and techniques like 
the continuous catheter placement in the plexus have evolved. These 
adjuvant drugs ideally are expected to prolong the analgesic effect 
without causing any side effects or prolonging motor blockade. 
Commonly used adjuvants to local anaesthetic solution are epinephrine, 
sodium bicarbonate, alpha  2 agonists like clonidine, dexmeditomedine, 
opioids like fentanyl, buprenorphine and steroids like dexamethasone. 
 
This study is intended to compare the supraclaviuclar brachial plexus 
blockade by two different approaches with regard to 1)the success rate, 
2)time required to perform the block, 3)onset of blockade, 4)sensory 
block level to pin prick, 5)complications and 6)requirement of rescue 
analgesia.  
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AIM AND OBJECTIVES 
To compare the Subclavian perivascular and Parascalene approach of  
supraclavicular brachial plexus block  
OBJECTIVES: 
To evaluate 
 Clinical success rate of block. 
 Time required to perform the block. 
 Onset of sensory, motor block and surgical adequacy.  
 Level of sensory block to pin prick. 
 Complications   
 Rescue analgesia 
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ANATOMY OF BRACHIAL PLEXUS11-15 
Mastering the Brachial Plexus anatomy and its distribution is 
absolutely essential for the precise and effective use of brachial plexus 
analgesia for surgeries of the upper limb. A thorough understanding of 
the vascular, muscular and fascial relationships of the plexus throughout 
its formation and distribution is equally essential in order to perform the 
various techniques of brachial plexus blocks. 
 
The Upper limb is innervated by Brachial plexus. The plexus consists of  
1. Roots 
2. Trunks 
3. Divisions 
4. Cords 
5. Branches 
This is formed by Ventral rami of 5th to 8th Cervical and 1st Thoracic 
nerves. It receives occasional contributions from 4th Cervical (prefixed) 
above and 2nd Thoracic nerve (post fixed) below. These nerves unite to 
form trunks, which lie in the neck above the Clavicle. It passes through 
the fascia enclosed space between the Scalenus Anterior and the Scalenus 
Medius muscle. It is accompanied by the Subclavian Artery. It enters the 
fascia over the muscle and forms the neurovascular bundle. This fascia 
becomes the axillary sheath in the axilla. 
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RELATIONS OF BRACHIAL PLEXUS 
 
Anterior relations 
The skin, superficial fascia, platysma and supraclavicular branches 
of the superficial cervical plexus, the deep fascia and external jugular 
vein. The clavicle is in front of the lower part and scalenus anterior is in 
front of the upper part. 
Posterior relations 
Scalenus medius and the long thoracic nerve of Bell. 
Inferior relations 
Related to the first rib. 
Superior relations 
Lies first above and then lateral to the subclavian artery. 
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Middle and inferior cervical sympathetic ganglion gives sympathetic 
contribution to the plexus 
ANATOMICAL ILLUSTRATION OF THE BRACHIAL PLEXUS 
                                         Axilla            /           Behind Clavicle          /   Posterior   /     
Between   
                                                                                                                       Triangle          
Scalene         
                                                                                                                                                
muscles 
 
Roots  
 Formed by the ventral rami of spinal nerves C5-C8 and T1 
(occasionally C4 or T2). 
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Trunks  
 Upper trunk – anterior rami of C5 & C6 joins to form the upper 
trunk 
 Middle trunk – formed by anterior ramus of C7 
 Lower trunk – anterior rami of C8 & T1. 
Divisions  
 Trunks divide into two divisions, namely 3 anterior divisions and 3 
posterior divisions. 
Cords  
 Lateral cord – anterior divisions of upper and middle trunks (C5 – 
C7) 
 Medial cord – anterior divisions of lower trunk (C8 – T1) 
 Posterior cord – posterior divisions of all the three trunks (C5 – T1) 
Branches  
From roots 
 Nerve to serratus anterior C5 – C7 
 Muscular branches to long cervices muscle C5 – C8 
 Nerve to the three scalene muscles C5 – C8 
 Nerve to rhomboids, levator scapulae C5 
 A branch to phrenic nerve C5 
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 Nerve to subclavius muscle C5 & C6 
From trunks 
 Suprascapular nerve C5 & C6 
From cords ( in relation to axillary artery ) 
 Lateral cords (three): 
 Lateral pectoral nerve C5 – C7 
 Lateral root of the median nerve C5 – C7 
 Musculocutaneous nerve C5 – C7 
 Medial cord (five): 
 Medial root of median nerve C8 – T1 
 Medial pectoral nerve C8 – T1 
 Medial cutaneous nerve of forearm C8 – T1 
 Medial cutaneous nerve of arm C8 – T1 
 Ulnar nerve C8 – T1 
 Posterior cord 
 Radial nerve C5 – T1 
 Axillary nerve C5 – C8 
 Thoraco dorsal nerve C6 – C8 
 Upper and lower subscapular nerves C5 – C6 
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SENSORY INNERVATION OF UPPER LIMB 
 
The upper arm (medial aspect) is not anesthetized by any brachial 
plexus block technique, since this area is innervated by the 
intercostobrachial nerve T2. This nerve can be blocked by subcutaneous 
infiltration across the upper medial aspect of the arm using 4 ml of local 
anaesthetic solution for surgical anaesthesia or tourniquet. Brachial 
plexus blockade can be done at the roots, trunks, cords or peripheral 
branches level. Each level of blockade has a specific distribution of 
anaesthesia, merits, demerits and complications. 
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PHARMACOLOGY37 
LOCAL ANAESTHETICS:  
Local anaesthetics are those drugs that produce reversible 
conduction blockade of impulses along central and peripheral nerve 
pathways after regional anaesthesia.  
They block the origination and also conduction of impulses 
pertaining to nerve mainly at all parts of specific neurone where they 
come in contact without causing any structural damage to the neurone 
Thus to say, not only sensory impulses but motor impulses are  also 
interrupted when this drug is being applied to a mixed nerve, leading on 
to muscular paralysis and loss of the autonomic control. 
HISTORY : 
Cocaine        - First introduced Local anaesthetic in 1884 by Koller  
                       in  ophthalmology.  
Prilocaine     - First introduced synthetic Local anaesthetic by  
                       Emborn in 1905 
Lignocaine   - Synthesized by Lofgren in 1943 
Bupivacaine - Synthesized by Ekenstam in 1956, introduced in   
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                         clinical practice by Telivuo in 1963 
The local anaesthetics are classified into   
 Amide group 
 Ester group 
ESTER LINKED TYPE LOCAL ANAESTHETICS: 
 COCAINE 
 CHLOROPROCAINE 
 PROCAINE 
 TETRACAINE 
 BENZOCAINE 
 
AMIDE LINKED LOCAL ANAESTHETICS: 
                  
 LIGNOCAINE 
 BUPIVACAINE 
 DIBUCAINE 
 PRILOCAINE 
 ROPIVACAINE 
The clinically useful type of local anaesthetic drugs are the poorly 
water soluble, weak bases with amphiphilic type of property. The 
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chemical structure of the drug consists of secondary  or  tertiary  type  of  
amine  (hydrophilic) on  one  side and  an aromatic residue  on  the  other 
side (lipophilic) with hydrocarbon chain in the middle. The hydrocarbon 
chain and lipophilic aroma tic ring are joined by an  ester  type  or  amide  
type  linkage – basis for classification of local anaesthetics.  
Marketed as water soluble hydrochloride salts – its acidic pH 
contributes to the stability of local anaesthetics. Acidic pH is important 
especially when epinephrine, which is unstable at alkaline pH, is added to 
the local anaesthetic.  
Features of amide local anaesthetics are found to be in contrast to 
ester type local anaesthetics. 
Amide local anaesthetics are specific in the following features : 
 Produce much intense and a longer lasting anaesthesia  
 Bind to the protein alpha 1 acid glycoprotein in plasma  
 Not at all hydrolysed by the enzyme plasma esterases 
 Very rarely may cause hypersensitivity reactions. No reported 
cross sensitivity has been seen with ester type local anaesthetics ( 
produce metabolites related to paraaminobenzoic acid which 
evokes allergic reactions ) 
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ADDITIVES: 
 Liposomal : To prolong duration of action and reduces systemic 
toxicity 
 Alkalinisation :  
 Shortens onset of neural blockade 
 Enhances the depth of motor and sensory blockade 
 Increases the spread of epidural blockade 
 Epinephrine :  
 Duration of action of local anaesthetics is directly proportional 
to the time the drug is in contact with nerve fibres 
 As most local anaesthetics have intrinsic vasodilator  property ( 
except ropivacaine and levobupivacaine ), addition of 
epinephrine ( 1: 2,00,000 or 5 mcg/ml ) 
 Decreases systemic absorption 
 Increases duration of action 
 Increases conduction blockade by increasing neuronal 
uptake of local anaesthetics 
 Its alpha adrenergic effect also causes some degree of 
analgesic effects 
 Low molecular weight dextran : Prolongs duration of action and 
decreases rate of systemic absorption  
 
19 
 
MECHANISM OF LOCAL ANAESTHETIC DRUG ACTION: 
These drugs are found to block the conduction of nerve impulses 
by decreasing the penetration of sodium ions in the period of upstroke of 
the action potential. 
Local anesthetics bind to alpha subunit of inner portion of Na+ 
channel 
Inhibits the passage of Na+ ions through ion selective Na+ channel 
Rate of depolarization slows 
Threshold potential not attained 
No propagation of action potential 
Conduction blockade 
OTHER SITES OF ACTION : 
 Blockade of voltage dependent K+ channel 
 L type calcium channel blockade 
 G protein coupled receptors 
FREQUENCY DEPENDENT BLOCKADE: 
 Local anaesthetics gain access to receptors only when Na+ channel 
is in activated open state 
 Depends on nerve’s characteristic frequency activity as well as to 
its anatomic properties 
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Hence to say here is, the nerve is actually resistant to the action of 
blocking in the resting state and the blockade develops rapidly in 
repeatedly stimulated  nerve. 
The frequency of this multiple stimulation is also a contributing factor 
on which the degree of  blockade is relying. So the degree of blockade 
relies on many vital factors. 
Greater level of blockade quality has been seen with higher 
stimulation frequency. And moreover the exposure to a large 
concentration of calcium is actually seen to decrease the inactivation of 
sodium channels and thereby it  is lessening the degree of the block. This 
process of interruption of impulses travel by these local anesthetic drugs 
are found to be not mainly due to the hyperpolarisation but indeed the 
resting potential of the membrane is not changed because the channels of 
potassium will be getting blocked only at a very high local anesthetic 
level. 
LOCAL ANAESTHETICS Pka 
AMIDES 
Bupivacaine and Ropivacaine 8.1 
Lignocaine  and Prilocaine 7.8 
Etidocaine 7.7 
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Mepivacaine 7.6 
ESTERS 
Chloroprocaine 9.0 
Procaine 8.9 
Cocaine 8.7 
Tetracaine 8.2 
 
The onset of blockade is linked to drug’s own status of p -ka. 
Those drugs with lesser p –ka (ex. Lignocaine, Mepivacaine ) are found 
to have quick onset of action, the reason for this being, nearly 30% to 
40% of that drug is in the base form without dissociation at the normal 
body level p-H of 7.4 and this exact form is going to penetrate the axon. 
The drugs which are actually found to be having high p-ka values 
namely: 
 Procaine 
 Tetracaine 
 Bupivacaine 
are really having slower onset of action as 15% is in base form without 
ionization except chloroprocaine which has quicker onset of action even 
though it is  possessing a high rate of p-ka of as high as 9.1. 
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MINIMUM CONCENTRATION (Cm) : 
 Necessary to produce conduction blockade 
 Directly proportional to nerve fibre diameter 
 Indirectly proportional to 
 pH of tissue 
 Frequency of nerve stimulation 
PHARMACOKINETICS : 
 Absorption depends upon 
 Site of injection 
 Dosage 
 Use of epinephrine 
 Pharmacologic characters of drug used 
 Plasma concentration depends upon 
 Tissue distribution 
 Rate of clearance of drug 
 Distribution depends upon 
 Lipid solubility 
 Protein binding 
 Cardiovascular status 
 Hepatic function 
 Age 
23 
 
 LUNG EXTRACTION : 
 Lung is capable of extracting lidocaine, bupivacaine, prilocaine 
from circulation thereby limiting the concentration of drug 
reaching systemic circulation 
 Propanolol impairs bupivacaine extraction by lungs, it also 
decreases plasma clearance of lidocaine and bupivacaine by 
reducing blood flow to the liver and hepatic metabolism 
inhibition 
 PLACENTAL TRANSFER : 
 Plasma protein binding influences rate and degree of diffusion 
of local anaesthetics across the placenta(   protein binding        
   placental transfer ) 
 Ester local anaesthetics due to rapid hydrolysis have very low 
rate of placental transfer. 
 Acidosis in foetus due to prolonged labour causes accumulation 
of local anaesthetics in the foetus ( Ion trapping ) 
 The degree of  ionization and lipid solubility of the drug 
determine the extent of placental transfer. Rate of placental 
transfer is low with lipid insoluble, ionized drugs 
 CLEARANCE : 
 Amide local anaesthetics – depends on hepatic metabolism 
 Ester local anaesthetics – by rapid hydrolysis in plasma/liver 
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 METABOLISM : 
 Amide local anaesthetics – Microsomal enzymes in the liver 
 Ester local anaesthetics – Hydrolysis in plasma/liver   
( cholinesterase enzyme ) 
 Renal elimination of unchanged drug is less than 5% as local 
anaesthetics are poorly water soluble 
RACEMIC MIXTURES : 
 Pipecoloxylidide local anaesthetics ( Bupivacaine, Levo 
bupivacaine, Ropivacaine, Mepivacaine ) are chiral drugs – Their 
molecular structure possess asymmetric carbon atom 
 Enantiomers of a chiral drug may vary in their pharmacodynamics, 
pharmacokinetics and toxicity 
 S enantiomers are considered to produce less neurotoxicity and 
cardio toxicity 
SIDE EFFECTS : 
ALLERGIC REACTIONS : 
 Account for <1% of adverse reactions to local anaesthetics. 
Majority of adverse responses are due to excess local anesthetic plasma 
concentrations. More common in ester linked local anesthetics. 
Manifestations like rash, urticaria, laryngeal edema, hypotension 
and bronchospasm is highly suggestive of a local anesthetic induced 
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allergic reaction. Accidental intravascular injection of the local anesthetic 
with adrenaline manifests as hypotension associated with syncope or 
tachycardia. 
Use of an intradermal test requires injection of preservative free 
preparations of local anesthetic solutions. 
Local Anaesthetic Therapeutic plasma 
concentration 
Lidocaine 1 – 5 mcg/ml 
Bupivacaine < 3 mcg/ml 
 
SYSTEMIC ACTION PERTAINING TO LOCAL 
ANAESTHETICS: 
Any of the local anaesthetic drug when it is injected or if it is 
locally applied, it will be absorbed into the circulation and produces 
deleterious effects on the vital organs when the concentration of the drug 
exceeds the toxic limits. 
CENTRAL NERVOUS SYSTEM : 
NEURAL SYSTEM: 
All these locally acting drugs produce continuous events of 
stimulation and that is sequentially followed by depression. The powerful 
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CNS STIMULATING drug, the so called cocaine drug - in sequence it 
causes   
 Euphoria 
 Increased excitability 
 Confusion 
 Restlessness 
 Tremor 
 Muscle twitches 
 Convulsive events 
 Unconscious state 
 Respiratory depression 
 Finally  - death 
The above clinical features depend on plasma concentration level. 
Numbness of the tongue and circumoral tissues is the first sign of local 
anaesthetic toxicity – reflecting drug delivery to highly vascular tissues. 
As plasma concentration of local anesthetics increase, it crosses blood 
brain barrier causes restlessness, skeletal muscle twitching (first seen in 
face and extremities), vertigo, tinnitus, slurred speech, difficulty in 
focussing and it predicts the onset of tonic clonic seizures. Seizures 
classically followed by central nervous system depression accompanied 
by hypotension and apnoea. 
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1. SEIZURES  
CAUSES : 
 Unopposed excitatory pathways due to selective depression of 
inhibitory cortical neurons by local anaesthetics 
 Inhibition of the release of neurotransmitters particularly gamma 
aminobutyric acid 
Local Anaesthetic Plasma concentration associated 
with CNS effects 
Lidocaine, Mepivacaine, Prilocaine 5 – 10 mcg/ml 
Bupivacaine 4.5 – 5.5 mcg/ml 
 
It is recommended that the plasma venous concentration of 
lidocaine should be monitored when the cumulative epidural does of 
lidocaine is > 900mg 
There is an inverse relationship between PaCo2 and seizure 
threshold, reflecting variations in cerebral blood flow and resultant 
delivery of drugs in the brain. Hyperkalemia can facilitate depolarisation 
and increase local anaesthetic toxicity. 
Treatment – Ventilation of patient’s lungs with oxygen, Intravenous 
benzodiazepines, Hyperventilation of lungs ( controversial ) 
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2. TRANSIENT NEUROLOGICAL SYMPTOMS : 
 Manifest as severe pain in the posterior thighs buttocks and lower 
back 
 Incidence  –  Increased in hyperbaric lidocaine, addition of 
adrenaline  
 Etiology      –  Not known 
 Onset          –  6 to 36 hours after recovery from spinal anaesthesia 
 Recovery    –  1 to 7 days 
3. CAUDA EQUINA SYNDROME : 
 Diffuse injury across the lumbosacral plexus 
 Manifest as Paraplegia, bowel and bladder sphincter dysfunction, 
sensory anaesthesia 
4. ANTERIOR SPINAL ARTERY SYNDROME :  
 Manifest as lower extremity paresis with a variable sensory deficit 
 Etiology – Uncertain 
 Risk factors – Advanced age, Peripheral vascular disease 
 Differential diagnosis – Epidural abscess or hematoma 
compressing spinal cord 
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CARDIOVASCULAR EFFECTS : 
 Bupivacaine produces cardiovascular depression and arrhythmias 
at high doses or during accidental intravascular administration. 
 The effects on cardiac tissue are : 
 Automaticity depressed 
 Excitability reduced 
 Contractility blunted 
 Conductivity slowed 
 Effective period of refractoriness lengthened 
The above effects on the cardiac tissue are caused by the following 
actions: 
 Blockade of Sodium, Potassium, Calcium channels 
 Direct myocardial depression 
 Relaxation of arteriolar smooth muscles 
 Inhibition of cyclic adenosine mono phosphate 
Risk Factors : 
 Pregnant mothers are highly sensitive to local anaesthetic drugs. 
 Patient on Beta  adrenergic blockers, Calcium channel blockers, 
Digitalis, Anti dysrhythmic drugs 
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 Tachycardia, use of phenylephrine, epinephrine  
Local Anaesthetic Plasma concentration associated with 
CVS effects 
Lidocaine 5 – 10 mcg/ml 
Bupivacaine 8 – 10 mcg/ml 
 
Mechanism Of Action : 
 All local anaesthetics prolongs  P – R and QRS interval by 
depressing the Vmax (maximal depolarization rate of the cardiac 
action potential ) 
 Both bupivacaine and lidocaine block cardiac sodium channels 
during systole, whereas during diastole, highly lipid soluble 
bupivacaine dissociates off at a slow rate – accounts for the 
persistent depressant effect on  Vmax and cardiac toxicity (also 
through direct brainstem effect ) 
 Bupivacaine is notorious to produce Ventricular  tachycardia and 
fibrillation. 
Treatment : 
 The patient must be ventilated with 100% oxygen 
 Basic and advanced cardiac life support must be initiated. 
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 Bretylium, sotalol and amiadarone are drugs of choices for 
bupivacaine induced arrhythmias. 
 Lipid emulsion  ( 20% ) therapy : 
 Bolus – 1.5 ml/kg (lean body mass) intravenously over 1 min 
followed by continuous infusion of 0.25 ml/kg/min  
 Recommended approach – Implement lipid therapy on the 
basis of clinical severity and rate of progression of  local 
anaesthetic toxicity  
 If there is persistent cardiovascular collapse, repeat bolus 
once or twice and double the infusion rate to 0.5ml/kg/min 
 Continue infusion for at least 10 minutes after attaining 
circulatory stability 
 Recommended upper limit : Approximately 10 mL/kg over 
the first 30 minutes 
 Avoid vasopression, calcium channel blockers, beta blockers  
 Reduce individual epinephrine doses to < 1mcg/kg ( Epinephrine 
can impair resuscitation from local anaesthetic systemic toxicity ) 
METHEMOGLOBINEMIA : 
 Rare but potentially life threatening complication 
 Caused by prilocaine, benzocaine, cetacaine, lidocaine, 
nitroglycerin, phenytoin and sulphonamides 
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 Central cyanosis usually occurs when methemoglobin 
concentration exceeds > 15% 
 Confirmed by qualitative measurements of methemoglobin  by 
cooximetry 
 Treatment : 
 Methylene blue – 1 - 2mg/kg IV over 5 minutes 
VENTILATORY RESPONSE TO HYPOXIA : 
 Lidocaine decreases and bupivacaine stimulates the ventilatory 
response to carbondioxide. 
HEPATOTOXICITY : 
 Bupivacaine causes elevated liver transaminases. 
 Injury can be direct toxic, an allergic reaction (most likely ) or 
idiosyncratic metabolic abnormality 
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PHARMACOLOGY OF BUPIVACAINE 
Bupivacaine:      
The chemical structure of Bupivacaine is 1-butyl-2-
piperidylformo-2’, 6’-xylidide hydrochloride. It belongs to the amide 
class of local anaesthetic drugs. 
 
Molecular structure: 
                         
 
Molecular formula: C18H29ClN2O  
It is an amino amide type of long acting local anaesthetic agent.  
 
Presentation: 
As a clear colourless 0.25%, 0.5% solution. 
 
Physiochemical properties18: 
 Molecular weight               : 288 
 Pka                                     : 8.1 
 Liposolubility                     : 30 
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 Partition coefficient              : 346 
 Protein binding                     : 95% 
 Vd                                        : 54 L 
 Elimination T1/2                    : 157 min 
 Clearance                             : 0.32 L/min 
 Onset of action                     : 1 - 17 min  (route and dose- 
                                             dependent) 
 Duration of action                : 2 - 9 hr  (route and dose- 
                                                dependent) 
 Half life                                : Neonates -  8.1 hr, Adults -  2.7 hr 
 Time to peak plasma 
             concentration (for peripheral, 
             epidural or caudal block)       : 30-45 min 
 Metabolism                           : Hepatic  
 Excretion                              : Renal (6% unchanged) 
 Fetal/Maternal ratio               : 0.2 - 0.4 
 
The molecules of bupivacaine have an asymmetric carbon atom, 
with a chiral centre, which exhibits optical isomerism. So commercial 
preparation of bupivacaine contains 50:50 ratio of Levo and Dextro 
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rotatory isomer. So the presence of both the isomers is called a Racemic 
mixture. 
Pharmacodynamics: 
In general, the diameter, myelination and conduction velocity of 
affected nerve fibres determine the progression of anaesthesia. Small 
fibres are more sensitive than larger fibres17 and require a longer period 
for recovery. Sensory pain fibres are usually blocked first, followed by 
fibres that transmit sensations of temperature, touch, and deep pressure. 
Unmyelinated nerves are blocked more readily than myelinated nerves.  
Pharmacokinetics:  
The absorption of local anaesthetic is related to the site of injection 
(intercostal > epidural > brachial plexus > subcutaneous). The total dose 
and peak plasma concentration have linear relationship. Dosage is 
2.5mg/kg, maximum dose – 175mg. 
Bupivacaine is mainly bound to alpha 1 acid glycoprotein. It is 
more protein bound (95%). Less than 3% of bupivacaine circulates free in 
plasma. The free concentration of the drug is responsible for the toxic 
manifestations.   
In protein deficient conditions like under nutrition and nephrotic 
syndrome, less amount of protein will be available to bind the drug 
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leading to increased free fraction of the drug, causing toxic 
manifestations even at minimal doses. 
The drug metabolism occurs mainly in the liver. Hepatic 
Cytochrome P450 plays major role in the metabolism. Mainly CYP1A2 
and CYP3A4 isoform. Aromatic hydroxylation, N – dealkylation, amide 
hydrolysis and conjugation are possible metabolic pathways. Excretion 
occurs mainly in the renal system and partly in the faeces. 
 
Hepatic Cytochrome enzyme system mediated metabolism of 
bupivacaine produce metabolites. The major metabolite of bupivacaine 
measured in blood or urine after spinal/epidural anaesthesia is N 
desbutylbupivacaine.  
. 
Uses 
Bupivacaine is used in Epidural analgesia, subarachnoid block, 
regional nerve blocks, retrobulbar block in the ophthalmic surgeries, and 
local infiltration. 
 
Spinal anaesthesia: 
Bupivacaine is most commonly used in spinal anaesthesia than 
lidocaine as lidocaine produces higher incidence of transient neurologic 
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symptoms. The onset time of sensory and motor blockade of hyperbaric 
bupivacaine is less when compared to isobaric bupivacaine.  Addition of 
opioid with bupivacaine results in improved quality of both sensory and 
motor blockade with less hemodynamic alterations. In parturients the 
intrathecal placement of bupivacaine along with sufentail provided labor 
analgesia and allowed the patients to ambulate.  
Stout’s principles for spread of solutions : 
 Height of anesthesia varies directly with concentration 
 Extent of anesthesia is directly proportional to speed of injection, 
volume of fluid, specific gravity of hyperbaric solutions 
 Extent of anesthesia is inversely proportional to rapidity of 
fixation, spinal fluid pressure 
 With isobaric or hypobaric solutions, extent depends on position of 
the patient 
Physiological effects: 
Hypotension (33%), bradycardia (13%) at higher level of blockade, eg. 
above T4. 
 
Epidural anaesthesia: 
Bupivacaine produces prolonged sensory blockade. Motor 
anaesthesia is more intense and of longer duration. The addition of 
epinephrine 1:2,00,000 does not appear to offer an advantage in terms of 
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duration of action. Epidural anaesthesia for labour or caesarean delivery 
is similar with 0.5% bupivacaine or ropivacaine. 0.25% bupivacaine and 
0.25% ropivacaine administered as intermittent doses into the epidural 
space are equally efficacious in providing relief of labour pain. More lipid 
solubility and protein binding of bupivacaine, limits its passage across the 
placenta to foetus.  
 
Post operative analgesia: 
Epidural analgesia:  
Similar doses of bupivacaine, levobupivacaine and ropivacaine 
produce comparable post operative pain relief. A continuous infusion of 
bupivacaine in lower dilutions with additives produces an effective 
postoperative pain relief. 
 
Wound infiltration:  
In a concentration of 0.125%, post incision wound infiltration 
produces good post operative analgesia following various surgeries. 
 
Regional nerve block: 
  Prolonged duration of blockade with good postoperative analgesia 
and less toxicity makes it as an ideal choice for nerve blocks. Addition of 
opioids appears to be ineffective in altering the results of the block 
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Ophthalmic surgery : 
  Bupivacaine  produces effective peribulbar anaesthesia and better 
post operative analgesia than ropivacaine. 
Paediatric anaesthesia:   
In paediatric patients, there is no difference with regard to 
postoperative analgesia provided by bupivacaine, levobupivacaine and 
ropivacaine. It is increasingly used in spinal anaesthesia, caudal blocks, 
epidural anaesthesia and continuous epidural infusion for post operative 
pain relief. For infant spinal anaesthesia the appropriate dose is 1mg/kg 
for bupivacaine and ropivacaine (0.5%). For caudal blocks the 
recommended dose is 2mg/kg.  
Adverse effects 
  Fall in blood pressure (33%) followed by nausea (21%), vomiting 
(14%), headache (9%), procedural pain (8%) and dizziness (6%).  
Allergic manifestations are rare. Accidental intravascular injection 
produces systemic toxicity. 
Drug interactions  
Hepatic Cytochrome enzyme inhibitors such as ketaconazole and 
methyl xanthenes affects bupivacaine metabolism. 
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LIGNOCAINE 
Lignocaine was synthesized in 1943 in Sweden by Loffgren of AB 
Astra. It is chemically a tertiary amide, diethyl aminoacetyl, 2.6, xylidine 
hydrochloride monohydrate. It is a local anaesthetic of moderate potency 
and duration but of good penetrative powers and rapid onset of action. 
 It is a stable compound at room temperature. Epinephrine prolongs 
the action of lignocaine and reduces the rate of systemic absorption by 
producing vasoconstriction and also reduces the systemic toxicity. 
Tachyphylaxis can occur with repeated injections. Concentration of 
epinephrine added is kept at 5 mcg / ml (1: 200,000 dilution) of Local 
anesthetic. 
Pharmacokinetics 
Molecular weight                            -  271 
Pka                                                  -  7.8 
Protein binding                               -  70% 
Lipid solubility                               -   2.9 
Volume of distribution                   -  91 litres 
Clearance                                        -  0.95 litres / minute 
Elimination half life                        -  96 minutes 
Metabolism 
The principle metabolic pathway of lidocaine is oxidative 
dealkylation in Liver to monoethylglycine xylilide followed by hydrolysis 
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of this metabolite to xylidide. Hepatic disease can decrease the rate of 
metabolism of Lidocaine. 
Dose : 
 Safe dose 3mg/kg without epinephrine 
 7mg/kg with epinephrine 
 Epinephrine upto 5 mcg /ml (1 in 200,000) does not give rise to 
systemic effects Blood concentration of local anaesthetic drug is 
highest following intercostal block followed in order of decreasing 
concentration, epidural, brachial plexus block and subcutaneous 
infiltration. 
Therapeutic uses : 
 Topical anaesthesia (2-4%) 
 EMLA Cream (eutectic mixture of lignocaine 2.5%, prilocaine 
2.5%) 
 Local infiltration and peripheral nerve block 
 Regional anaesthesia (Spinal / epidural) 
 Intravenous regional anaesthesia (Biers block) 
 Stress attenuation and prevention of rise in intra cranial tension, 
suppression of the ventricular cardiac dysrhythmias (using 
preservative free lignocaine ) 
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PHYSIOLOGICAL BASIS OF PERIPHERAL NERVE 
STIMULATOR TECHNOLOGY 
Nerve stimulation was first described by Perthes in 1912. Electrical 
Nerve stimulation of peripheral nerves is now more commonly used in 
clinical practice. The ability of a nerve stimulator to evoke a motor 
response depends on the intensity, duration, and polarity of the 
stimulating current used and the {needle (stimulus) - nerve } distance. 
Application of threshold current to the nerve fibres is essential to 
propagate a nerve impulse. Peripheral nerve stimulation is typically 
performed using a rectangular pulse of current.  
RHEOBASE is the minimal threshold current required to stimulate 
a nerve with along pulse width. 
CHRONAXIE is the minimum duration of a stimulus required to 
stimulate a nerve at twice the strength of rheobase.  Chronaxie is used to 
express the relative excitabilities of different tissues. It is possible to 
stimulate A- alpha (motor) fibres without stimulating A-delta and C fibres 
that transmit pain. Moreover, mixed nerves can be located by evoking a 
motor response without causing patient discomfort.  
Intensity of stimulation will be variable as determined by 
coulomb’s law [e = k (q/r 2) k - constant, q - minimum stimulating 
current, r - distance of the needle tip from the nerve]. 
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 A very high stimulus current is required for nerve stimulation 
when the distance between needle tip and the nerve is far. If there is great 
distance, the stimulus strength required to stimulate the nerve may 
produce significant pain and systemic effects. A stimulating current of 
<0.5 mA is associated with high rates of success of peripheral nerve 
stimulator assisted peripheral nerve block. 
Characteristics of an ideal peripheral nerve stimulator (PNS) : 
1. Constant current output - A particular current not the voltage 
stimulates the nerve. Therefore, the current delivered by the device 
should not vary with changes in the resistance of the external 
circuits. 
2. Digital display of the delivered current 
3. Variable output control 
4. Clearly identifiable control 
5. Option for different pulses 
6. A wide range of current output 0.1-5.0mA 
7. Battery indicator 
Peripheral nerve stimulator settings 
MIXED NERVE (eg - Sciatic nerve ) 
Current(dial)              -  1 mA 
Current duration        -  0.1 ms 
Frequency                  -  1 - 2 Hz 
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SENSORY NERVE (eg- Lateral femoral cutaneous and saphenous 
nerves) 
Current (dial)             -  2 - 5mA 
Current duration        -  1 ms 
Frequency                 -  1 Hz 
DIABETIC NEUROPATHY 
Current (dial)            -  2 mA 
Current duration       -  0.3 ms 
Frequency                 -  1-2 HZ 
PERIPHERAL NEUROANATOMY 
C and A fibres are the main peripheral nociceptors. The skin joints 
and periosteum are richly innervated with C and A  nociceptors as well 
as the non nociecptive AB sensory fibres. 
A  are responsible for the sensation of first pain, the initial sharp pain 
experienced following an injury. C fibres are unmyelinated and are 
responsible for second pain, the slowly building throbbing burning pain 
experienced following an injury. 
Peripheral neurochemistry and neurotransmitters: 
Commonly released inflammatory mediators implicated in pain and 
hyperalgesia include bradykinins, potassium, substance P cytokines, 
histamine, serotonin and prostaglandins ( it is here that dexamethasone 
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plays a vital role in prolonging analgesia in nerve blocks when used as an 
additive ). These peripheral neurotransmitters either activate or sensitise 
the peripheral noiceptors to pain 
Classification of Sensory Fibers 
Sensory 
receptors 
Speed of 
transmission 
Sensory function Myelination 
C Fibres 0.5 -2m/sec 
Noxious chemical, 
Mechanical, thermal 
activation (Slow burning 
second pain) 
Unmyelinated 
A-Alpha 
fibres 
70 -120m/sec 
Noxious chemical thermal, 
mechanical stimuli, (sharp 
fast, first pain) 
Lightly 
myelinated 
A-Beta 
fibres 
30 -70m/sec 
Nonpainful, light,touch, 
pressure, vibration 
proprioception 
Heavily 
myelinated 
A-Gamma 
fibres 
30-70m/sec 
Proprioception/Motor to 
muscle spindle 
Myelinated 
A-δ fibres 12-30 m/sec Pain, cold, touch Myelinated 
B fibres 3 -15 m/sec 
Pre ganglionic autonomic 
(sympathetic ) 
Myelinated 
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PHARMACOKINETICS OF LOCAL ANAESTHETICS 
IN BRACHIAL PLEXUS BLOCKADE34 
 
When a local anaesthetic is injected around a nerve trunk, fibres 
situated in the periphery of the trunk (mantle fibres) will be first blocked 
and those in the centre of the trunk (core fibres) last. Further, 
transmission in peripherally placed fibres will be blocked over a longer 
length of time compared to central fibres. Thus analgesia will appear first 
and last longest in the territory supplied by the peripheral fibres. If the 
pool of local anaesthetics is small or if the injection was not accurate or 
too dilute, the fibres in the centre will escape blockade. 
Theory of Winnie 
The trunks are arranged so that the central fibres are the longest 
supplying the extremities of the limb while shorter fibres are arranged 
more peripherally as their area of supply is more proximal. Winnie 
groups the fibres into two: the peripheral mantle fibres which contain the 
motor fibres and core fibres which are mainly inner sensory. Peripheral 
motor fibres supply the muscles of the forearm and the central fibres 
carry sensation from the hand. 
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Thus the onset of block in the limb occurs  as follows: 
 Loss of motor power to the shoulder and upper arm 
 Loss of sensation on the upper arm 
 Loss of motor power of the forearm 
 Loss of sensation to the hand. 
 
So the spread of block is from proximal to distal. 
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REVIEW OF LITERATURE 
Technique and drug 
The supraclavicular brachial plexus block is one of several techniques 
of the brachial plexus block. The block is performed at the level of trunks 
of brachial plexus, confined to a very small surface area. It produces rapid 
onset, predictable and dense anaesthesia. Kulenkampff of Germany in 
1911 performed the first percutaneous supraclavicular approach. This 
technique was later published in 1928 by Kulenkampff and Perksy 
(classic approach).  
 
1. Vongvises, P., and Panijayanond described parascalene approach 
of brachial plexus block, conducted in 100 patients undergoing 
upper extremity surgery and found that  it was a useful, simple, 
safe, and reliable technique for brachial plexus block, avoiding the 
complication of pneumothorax (1979 )19 
2. Bernard dalens et al prospectively evaluated parascalene approach 
with subclavian perivascular approach in 120 children, 60 patients 
in each group. Insulated needles and a nerve stimulator were used 
with both techniques.  The parascalene approach proved  to be 
easier and more reliable while also being  almost free of  
complications, although both techniques produced  a high degree 
49 
 
of  sensory blockade in almost all  infraclavicular branches of  the 
brachial plexus (1987 )17 
3. Anaesthesia and analgesia vol: 60 (page 352 to 355) – No.5: May 
1981 Volker Hempel, MD," Meno van Finck, MD,f and Elmar 
Baumgartnerf. A Longitudinal  Supraclavicular  Approach to the 
Brachial Plexus for the Insertion of  Plastic Cannulas. 
4. Pramot Vongvises  et al conducted computed tomographic study of 
parascalene block  in  20 cases regarding the  relation between  the 
needle position to  the  brachial  plexus  and  the dome  of  the  
pleura and found that  in  the  parascalene  block, needle entry  site 
level  is  higher  to  the  dome  of  the  pleura,  thus  the  
complication of  pneumothorax  is  less.  (1997)18 
5. Kyung Hee kim, Keon Jung Yoon et al performed parascalene 
technique for brachial plexus block in 206 cases undergone upper 
extremity and shoulder surgeries, studied the cases retrospectively 
and concluded that this approach is safe, reliable method for 
providing proper anaesthesia for upper extremity and shoulder 
surgeries without any remarkable complications except Horner’s 
syndrome for 3 cases ( 1997 ) 
6. Carlo D. Franco prospectively collected data from 1001 subclavian 
perivascular brachial plexus blocks performed using nerve 
stimulator according to Winnie’s approach. Concluded the above 
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technique was both highly successful and safe without any 
complications (2000)20 
7. European Journal of Anaesthesiology: Volume 17, Issue 2, pages 
120–125, February 2000 : Brachial plexus block using a new 
subclavian perivascular technique: the proximal cranial needle 
approach. Department of Anaesthesia, Centro Traumatologico 
Ortopedico, Careggi, Firenze, Italy, Dr P. Pippa, Via A Righi, 28, 
I-50047 Prato, Italy. We describe the proximal cranial needle 
approach for brachial plexus blockade; clear surface markings and 
cranial direction of the needle lead to satisfactory results with a low 
incidence of complications. 
8. Regional Anaesthesia and Pain Medicine, Vol 27, No 4 (July–
August), 2002: pp 402–428. : Brachial Plexus Anaesthesia: 
Essentials Of Our Current Understanding Joseph M. Neal, M.D., 
James R. Hebl, M.D., J. C. Gerancher, M.D., and Quinn H. Hogan, 
M.D. 
9. Arauzo P., Ortega J. P compared axillary plexus block using nerve 
stimulator with parascalene block using paraesthesia technique for 
surgeries about the elbow on 64 patients and found that parascalene 
technique was easy to use and provide excellent anaesthetic 
condition for trauma surgery around the elbow without arm 
mobilization or the use of a nerve stimulator (2005). 
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10. Bhattarai BK, Baral PR compared Winnie’s subclavian 
perivascular approach with parascalene approach of brachial plexus 
block in 60 children. They concluded that parascalene approach 
can be used  as a sole anaesthetic technique in children undergoing 
surgeries around the elbow.(2006) 
11. Faramarz Mosaffa, Mohammad Mehdi Ghiamat conducted a study 
on 50 cases using parascalene approach of brachial plexus block by 
eliciting paraesthesia and concluded that the technique is simple, 
safe and reliable without any complications (2006) 
12. Nguyen Hoang C, Fath Erwin, Wirtz Sebastian, et al. Anesth. 
Analg. Sep 2007;105:872-5  
13. Young Duck Shin, Keun Seok Lee et al published a case report on 
parascalene brachial plexus block using ultrasound for performing 
arthroscopic shoulder surgery and found that Ultrasound 
technology is valuable to anaesthesiologists to localize nerves and 
the needle placement during the parascalene approach to block the 
brachial plexus (2009) 
14. Chethanananda T N, Ramesh M C conducted prospective non 
randomized open level study on subclavian perivascular technique 
of brachial plexus block on 66 patients undergoing elective upper 
limb surgeries. Their study concluded that  this approach 
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consistently provide an effective block for the surgery of the upper 
extremity.(2014) 
15. Alpaslan Apa, Hulya Basar conducted a study in 60 healthy adult 
patients using parascalene approach in Brachial plexus block using 
the surface landmarks based on bony prominences undergoing 
elective upper extremity surgery and found that the technique had 
high success rate and was considered a safe alternative to the 
classically described techniques. 
16. Regional Anaesthesia and Pain Medicine, Volume 25, Issue 1, 
Pages 41-46: C.Franco, Z.Vieira. 1,001 subclavian perivascular 
brachial plexus blocks: Success with a nerve stimulator.  
Results: Nine hundred seventy-three blocks (97.2%) were 
completely successful; 16 blocks (1.6%) were incomplete and 
needed supplementation; and 12 blocks (1.2%) failed and required 
general anaesthesia, giving a success rate for regional anaesthesia 
of  98.8%. 
Conclusions: The subclavian perivascular block consistently 
provides  an effective block for upper extremity surgery. We believe 
that we have demonstrated a nerve stimulator technique that is both 
highly successful and safe without any major complications. 
17. Transscalene Brachial Plexus Block: a New Posterolateral 
Approach for Brachial Plexus Block  
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Depending on the approach to the upper brachial plexus, 
severe complications have been reported. We describe a novel 
posterolateral approach for brachial plexus block which, from an 
anatomical and theoretical point of view, seems to offer 
advantages. 27 patients were scheduled to undergo elective 
major surgery of the upper arm or shoulder using this new trans -
scalene brachial plexus block. The success rate was 85.2% for 
surgery. 2 patients required additional analgesia with IV 
sufentanil. In two others, regional anaesthesia was inadequate.  
The side effects of this technique included reversible recurrent 
laryngeal nerve blockade in 2 patients and a reversible Horner 
syndrome in 1 patient. Further studies are needed to compare the 
trans -scalene brachial plexus block with other approaches to the 
brachial plexus 
18. Winnie AP, Collins VJ. The subclavian perivascular technique of 
brachial plexus anesthesia. Anesthesiology 1964; 25 : 353-63.  
19. Lanz E, Theiss D. Evaluation of brachial plexus block. 
Comparison between supraclavicular and interscalene approach. 
Anaesthesist 1979;28 : 57-62. 
20. Dupré LJ, Danel V, Legrand JJ, Stieglitz P. Surface landmarks for 
supraclavicular block of the brachial plexus. Anesth Analg 1982; 
61:28-31.   
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MATERIALS AND METHODOLOGY 
   60 patients of ASA I & II category of both sexes in the age group 
of 20 – 50 years posted for upper limb surgeries at the Department of 
Orthopaedics and the Department of  Plastic surgery, Government 
Kilpauk Medical College Hospital and Government Royapettah Hospital 
formed the study group. 
This study was designed as a prospective randomized comparative 
study. After receiving the approval of Institutional ethical committee and 
informed consent, the patients were randomly allocated into 2 groups 
receiving supraclavicular brachial plexus block with the help of  Inmed 
nerve stimulator (Group A – Subclavian perivascular approach and group 
B – Parascalene approach).  
 
Inclusion criteria 
 Consented patients 
 ASA I and II 
 20 – 50 years 
 Both sexes  
 Weight 50 – 70 kilograms 
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Exclusion criteria  
 Patients refusal  
 ASA III & ASA IV 
 Coagulation disorders 
 Allergy to any of the drugs used in the study 
 Any distortion of local anatomy, contractures 
 Local infection 
Equipment  
 Sterile tray 
 Sterile towel, gauze packs 
 Disposable 2ml, 5ml, 10ml syringes 
  Sterile gloves, marking pen and surface electrodes 
 50mm long, 22G short bevel insulated stimulating needle 
 Peripheral nerve locator 
Drugs  
 0.5% bupivacaine vial 
 2% lignocaine with adrenaline ( 1:2,00,000 ) vial 
Intraoperative and post operative monitor 
 Pulse oximeter 
 NIBP 
 ECG 
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A total of 60 patients who come under the above mentioned inclusion 
criteria were selected. Patients who were selected were counselled about 
the risks and benefits involved in performing the block. After getting 
informed and written consent, patients willing to be included in the study 
were enrolled and analyzed. 
 Patients were all preoperatively evaluated preoperatively, clinically 
examined. Proper investigations were done prior to the assessment. 
Procedures were explained in detail and written consent was obtained. 
All patients were kept in nil per oral state at least for 8 hours before 
taking up for the procedure. Intravenous access was obtained with 18G 
intavenous cannula. Local anaesthetic test dose was done. Inj. Ranitidine 
50 mg and Inj. Ondansetron 4 mg were given intravenously. All patients 
were pre medicated with Inj .Midazolam (0.02 – 0.05 mg/kg) 
intravenously 10 minutes before the procedure.  
Boyle machine, suctioning equipment, laryngoscope with blades of 
all sizes, endotracheal tubes, laryngeal mask airways, manual 
resuscitation bag with mask were kept ready. The procedure was carried 
out in the theatre where facilities for resuscitation were available. 
Before shifting the patient to operation theatre, patients were 
grouped into group A and group B by computer randomization. 
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Group A (n=30) receiving supraclavicular brachial plexus block using 
Subclavian perivascular approach  
Group B (n=30) receiving supraclavicular brachial plexus block using 
Parascalene approach 
Initially the pre procedure parameters were recorded i.e. Pulse rate, 
BP, SpO2 and ECG. Positioning of the patient and surface landmarks 
were similar in both groups. Needle insertion point only differs.  Then the 
block was administered under sterile aseptic precautions.  
Time to perform the block (from the skin puncture time to completion 
of injection of local anaesthetics), time for onset of sensory and motor 
blockade, complications, requirement of rescue analgesia were noted. 
Patients were monitored haemodynamically and observed vigilantly for 
development of any complications.  
Positioning of the patient during subclavian perivascular and 
parascalene blocks: 
 Patient placed in supine position with head turned to the side 
opposite to the side to be blocked. 
 The arms are at the patient’s side with the hands pointing towards 
the knee. 
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 The arm on the side to be blocked may be pulled to depress the 
clavicle and the shoulder. 
 A rolled towel is placed lengthwise between the shoulders along 
the spine to give the best exposure to the area. 
Surface landmarks  
Important landmarks for supraclavicular block include the 
interscalene groove behind the posterior border of the 
sternocleidomastoid muscle, subclavian pulse, the midpoint of the 
clavicle, and Chassaignac’s tubercle. The interscalene groove can be 
identified by placing a finger behind the sternocleidomastoid muscle and 
then rolling laterally to feel the groove in between the scalene anterior 
and scalene medius muscle. Manoeuvres help to identify landmarks 
include asking the patient to lift their head against resistance to identify 
sternocleidomastoid muscle. Sniffing accentuates the scalene muscles. 
The groove can be followed towards the clavicle.  
The needle puncture site in Group A (Subclavian perivascular 
technique) was identified by sliding the palpating finger down the 
interscalene groove till arterial pulsation of the subclavian artery was felt. 
The skin and subcutaneous tissue is infiltrated with 2ml of 2% lignocaine. 
A 22 G short bevel 50mm insulated needle was inserted in caudad 
direction till the fascial pop was felt after piercing the neurovascular 
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sheath. The direction of the needle will be dorsally tangential to 
subclavian artery in the longest dimension of interscalene space. 
The needle insertion point in Group B (parascalene technique) was 
identified by locating Chassaignac’s tubercle, the transverse process of 
C6, located by palpation in the interscalene groove, just posterior to the 
sternocleidomastoid muscle, at the level of the cricoid cartilage and a line 
drawn from it to the midpoint of the clavicle. The point dividing the 
upper two thirds and lower one third in the line was identified as the 
puncture site. The skin and subcutaneous tissue is infiltrated with 2ml of 
2% lignocaine. The needle, 22G, 50mm long  insulated short bevel 
needle, directed posteriorly at right angle to the skin. 
       In both groups, the block will be performed using a nerve stimulator 
connected to the proximal end of 50mm, 22 G insulated needle which is 
set at 3mA.  The needle position is adjusted while  decreasing the current 
to 0.5 mA until a constant motor contraction response of the middle and 
ring fingers were elicited. 
          A cough from the patient is a warning sign that the pleura is being 
contacted by the needle. Incremental doses of 15 ml , 0.5% bupivacaine 
with 15 ml ,2% lignocaine with adrenaline (1 : 2,00,000) injected slowly 
with intermittent aspiration as a precaution to avoid intravascular 
injection.  
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After injecting the local anaesthetic the block is tested for both 
sensory (using pin prick) and motor (using muscle power) and is 
compared with same stimulation or power in the contralateral arm. Motor 
block is evaluated by thumb abduction (Radial nerve), thumb adduction 
(Ulnar nerve), thumb opposition (Median nerve) and flexion of the elbow 
in supination and pronation of the forearm (Musculocutaneous). 
 The Hollmen’s scale is used in the study for assessing both 
sensory and motor blockade. 
Hollmen’s scale 
Sensory blockade (Grade) 
0  -  normal sensation of pin prick 
+      -  pin prick felt as sharp pointed but weaker compared 
with the same area in other extremity 
++    -  pin prick is felt as touch with blunt object 
+++  -  no perception of pin prick. 
Onset of blockade means minimum grade 2 and complete blockade 
means minimum grade 3 
Motor blockade (Grade) 
0  -  normal muscle function  
+ -  slight depression in muscle function as compared with  
pre-anesthetic power 
++     -  very weak muscle action persisting in muscle 
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+++   -  complete block with absent muscular function. 
      Onset of blockade means minimum grade 2 and complete blockade 
means minimum grade 3. 
Sensory and motor block were evaluated after completion of 
injection of local anaesthetic drug and time required for performing the 
block, the time of onset of sensory, motor block and surgical adequacy, 
level of sensory block to pin prick was noted. Post operatively patient 
was monitored for 24 hours 
Onset of blockade both sensory & motor is defined as a minimum 
of grade 2 in Hollmen’s scale. Block was considered complete when 
sensory and motor scores were atleast grade 3 in Hollmen’s scale.  
Patients in whom the block was insufficient, were supplemented 
with either Inj. Fentanyl (2 µ/kg) or local infiltration at the surgical site.  
Patients in whom the block was failed, were converted to general 
anaesthesia using Inj. Glycopyrrolate ( 5µ/kg ), Inj. Propofol (2mg/kg ), 
Inj. Atracurium ( 0.5mg/kg loading dose followed by 0.1mg/kg every 30 
minutes) and reversed with Inj. Neostigmine (50µ/kg ) and Inj. 
Glycopyrrolate (5µ/kg ) at the end of surgery. 
Monitoring  
Baseline vital signs Pulse rate/ BP/ SpO2 were recorded and 
monitored. Adverse events comprised more than 20% fall in blood 
pressure in the baseline value considered hypotension, <60 pulse rate per 
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minute considered as bradycardia, Spo2  of < 90% considered hypoxemia. 
If hypotension or bradycardia occurs it was treated accordingly.  
Time required for performing the block, Onset completion of 
blockade, duration of blockade, Level of sensory block to pin prick, 
Successful blockade, Complications of the block was assessed. 
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STATISTICAL TOOL  
  The information collected regarding all the selected cases were 
recorded in a Master Chart. Frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-
square test was used to test the significance of difference between 
quantitative variables and Yate’s chi square test for qualitative variables. 
A 'p' value less than 0.05 is taken to denote significant relationship. 
OBSERVATION AND RESULTS 
This study comprised of two groups. 
 Group – A: 30 patients received subclavian perivascular  approach . 
Group – B: 30 patients received Parascalene approach.  
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DEMOGRAPHIC PROFILE: ANALYSIS OF AGE AMONG THE 
GROUPS 
 Group N Mean 
Standard 
Deviation 
P-value 
Age(years) 
Group A 30 36.6 years 11.6 years 0.5385 
Not 
significant 
Group B 30 35.4 years 10.8 years 
 
 
  
The mean age in group A was 36.6 years ±  11.6 years standard 
deviation and in the group B it was 35.4 years ± 10.8 years standard 
deviation. P value = 0.5385: Not significant. 
 
36.6
35.4
34.5
35
35.5
36
36.5
37
Age
Group A
Group B
65 
 
ANALYSIS OF SEX DISTRIBUTION BETWEEN THE GROUPS 
Sex 
Group A Group B 
No % No % 
Male 24 80 18 60 
Female 6 20 12 40 
Total 30 100 30 100 
‘p’ 
0.159 
Not significant 
 
            
 
     Sex distribution in Group A was 24 males and 6 females and in the 
Group B were18 males and 12 females. P value is 0.159 - Not significant. 
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ANALYSIS OF WEIGHT AMONG THE GROUPS 
 Group N Mean 
Standard 
Deviation 
P-value 
Wt in Kg 
Group A 30 59.4 6.3 0.1693 
Not 
significant 
Group B 30 
57.1 
7.0 
 
     
 
The mean weight in Group A was 59.4 kgs ± 6.3 standard 
deviation and in the Group B it was 57.1 kgs ± 7.0 standard deviation. P 
value = 0.1693  Not significant.  
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ANALYSIS OF ASA STATUS AMONG GROUPS 
ASA status 
GROUP A GROUP B 
No % No % 
1 28 93.3 26 86.7 
2 2 6.7 4 13.3 
‘p’ 
0.3354 
Not significant 
 
           
ASA status of both the groups did not exhibit any significant 
difference (p = 0.3354). 
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ANALYSIS OF TIME TO PERFORM BLOCK AMONG GROUPS 
Parameter 
Time to perform block 
( in minutes) 
GROUP A GROUP B 
Mean 4.7 2.9 
SD 0.92 0.84 
‘p’ 
0.0001 
Significant 
 
          
Time to perform block in group – A with the mean of 4.7 and  
standard deviation of 0.92. Time to perform block in group – B with 
mean of 2.9 and standard deviation of 0.84.  p value is 0.0001- 
Significant. 
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ANALYSIS OF TIME FOR ONSET OF SENSORY BLOCK 
AMONG GROUPS 
Parameter 
Time for onset of sensory block 
( in minutes) 
GROUP A GROUP B 
Mean 6.13 6.2 
SD 1.28 1.42 
‘p’ 
0.8915 
Not significant 
 
      
Time for onset of sensory block Group – A with the mean value of 
6.13 and  standard deviation of 1.28. Time for onset of sensory block in 
group – B with mean value of 6.2 and standard deviation of 1.42. p value 
is 0.8915 – Not significant. 
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ANALYSIS OF TIME FOR ONSET OF MOTOR BLOCK 
AMONG GROUPS 
 
 
Parameter 
Time for onset of motor block  
( in minutes) 
GROUP A GROUP B 
Mean 11.87 11.93 
SD 1.68 1.78 
‘p’ 
0.8801 
Not significant 
 
         
Time for onset of motor block Group – A with the mean value of 
11.87 and  standard deviation of 1.68. Time for onset of motor block in 
group – B with mean value of 11.93 and standard deviation of 1.78. p  
value is  0.8801- Not significant.  
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ANALYSIS OF SUCCESS OF PROCEDURE AMONG GROUPS 
Success of procedure 
GROUP A GROUP B 
No % No % 
Complete 21 70 28 93.3 
Partial 9 30 2 6.7 
‘p’ 
0.0453 
Significant 
 
      
The procedure was more successful in the group B nearly about 
93.3%  compared with 70% of the group A. P value is  0.0453 – 
Significant. 
 
 
70
30
93.3
6.7
0
10
20
30
40
50
60
70
80
90
100
COMPLETE PARTIAL
GROUP A 
GROUP B
72 
 
ANALYSIS OF COMPLICATIONS AMONG GROUPS 
Complications 
GROUP A GROUP B 
No % No % 
Complete 7 23.3 - - 
Partial 23 76.7 30 100 
‘p’ 
0.0053 
Significant 
 
            
No complications in the group – A and 7 cases of complications  
like vessel injury in  Group B. P value is  0.0053 - Significant. 
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ANALYSIS OF RESCUE ANALGESIA REQUIREMENT AMONG 
GROUPS 
      
 
 
The Rescue analgesia requirement in the group B (6.7% ) is less 
than compared with 30% of the group A.  P value is < 0.05 – Significant. 
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GROUP A GROUP B 
No % No % 
Not Required  21 70 28 93.3 
Required 9 30 2 6.7 
P 
0.0053 
Significant 
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ANALYSIS OF LEVEL OF SENSORY BLOCK TO PIN PRICK 
AMONG GROUPS 
Level of sensory 
block to pin prick 
GROUP A GROUP B 
No % No % 
Shoulder level - - 23 76.7 
Mid arm level 30 100 7 23.3 
 
     
The Level of sensory block to pin prick upto the level shoulder 
level in the group B (76.7% ) is more than compared with group A. P 
value is < 0.05 – Significant. 
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COMPLICATIONS 
There were seven incidences of arterial puncture in the group A 
without formation of hematoma. Needle was again repositioned and drug 
administered.  Block was successful. There was no other incidence of 
 Pneumothorax 
• Post operative neurological deficit 
• Phrenic nerve palsy 
• Horner’s syndrome 
• Local anaesthetic toxicity 
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DISCUSSION 
Brachial plexus blockade offered an excellent alternative technique 
to general anaesthesia for upper limb surgical procedures. Various 
approaches for successful performance of the blocks and for reducing the 
complication have already been described but the two approaches 
adopted in this study were found to be easy to perform with a successful 
outcome. 
Supraclavicular technique was chosen for this study because it 
provides a rapid onset, dense and predictable anaesthesia with a high 
success rate. In this study two approaches of supraclavicular block are 
compared.  
        In the present study an attempt has been made to evaluate the 
subclavian perivascular approach on the clinical success rate of block, 
time required  for performing the block, onset of sensory, motor block 
and surgical adequacy, level of sensory block to pin prick, complications, 
rescue analgesic requirement and it was compared with parascalene 
approach group 
The analysis was based on demographic parameters like age, sex 
distribution and weight, time to perform the block, onset of sensory and 
motor blockade, success rate, level of sensory block to pin prick, 
complications and rescue analgesic requirement perioperatively. 
77 
 
Here in this study 60 patients were evaluated. They were randomly 
allocated to two groups i.e. group A (Subclavian perivascular approach 
group) and group B (Parascalene approach group). 
By statistical analysis of two groups the age distribution in both 
groups was statistically not significant with a ‘p’ value of 0.5385 (p> 
0.05).  
When comparing the weight of the patients in two groups it was 
statistically not significant with a p value of 0.1693  (p> 0.05). Both the 
groups were comparable in relation to age and weight. 
Time to Perform Block 
Time to perform block in group – B  (Parascalene approach ) with 
mean of 2.9 and standard deviation of 0.84, Group – A (subclavian  
perivascular approach ) with the mean of 4.7 and standard deviation of 
0.92. The difference was   statistically significant (p = 0.0001). 
Onset to Sensory Blockade 
Time for onset of sensory block in in group – B (Parascalene 
approach) with mean value of 6.2 and standard deviation of 1.42. Group – 
A (Subclavian perivascular approach ) with the mean value of 6.13 and 
standard deviation of 1.28. There was no significant difference (p = 
0.8915). 
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Onset of Motor Blockade 
Time for onset of motor block in in group – B (Parascalene 
approach) with mean value of 11.93 and standard deviation of 1.78. 
Group – A (Subclavian perivascular approach) with the mean value 
of 11.87 and  standard deviation of 1.68. There was no significant 
difference (p = 0.8801). 
Successful Block 
 The procedure was more successful in 93.3% of the group B 
(Parascalene approach group) compared with  70% of the group A 
(subclvian perivascular approach group) . The difference was statistically 
significant (p = 0.0453). 
Complications  
No complications in the group B (Parascalene approach group) 
compared to 7 cases of vessel injury in   group A (subclavian perivascular 
approach). This difference was statistically significant (p = 0.0053). 
Rescue analgesia requirement  
The rescue analgesia requirement in the group B (Parascalene 
approach group) (6.7% ) is less than compared with 30% of the group A 
(Subclavian perivascular approach group) . This difference was 
statistically significant (P < 0.05). 
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Level of sensory block to pin prick 
  The level of sensory block to pin prick upto the level shoulder level 
in the group B (Parascalene approach group) (76.7% ) is more than 
compared with group A (Subclavian perivascular group). This difference 
was statistically significant (P < 0.05). 
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SUMMARY  
1. Time to perform block was shorter in supraclavicular block by 
parascalene approach when compared to subclavian perivascular 
approach.  
2. Onset of both motor and sensory blockade were same in both groups. 
3. Success rate was 90% in group B (parascalene approach) when 
compared to group A (subclavian perivascular approach) 
4. Level of sensory block to pin prick was higher ( shoulder level) in 
parascalene approach compared with subclavian perivascular 
approach.   
5. Complication like pneumothorax was nil in both approaches, vessel 
injury nil in parascalene approach when compared to 7 incidences in 
the subclavian perivascular approach.   
6. Rescue analgesic requirement is less in group B, parascalene 
approach, when compared to group A, subclavian perivascular 
approach 
7. These inferences provide evidence of the supraclavicular block by 
Parascalene approach is a very effective brachial plexus block with 
distinct advantages. 
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CONCLUSION 
Supraclavicular block of brachial plexus by the parascalene 
approach provides an adequate sensory blockade and motor blockade, 
with less time to perform block, level of sensory block is higher ( upto 
shoulder ), high success rate and less complications when compared to 
subclavian perivascular approach. 
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PROFORMA 
Name:                                                  Age:  Sex:            IPno:                                                                
Ward/ SU Group: 
Date of admission:                                                 Date of surgery: 
ASA Physical Status: 
Co- Morbidity:                                                               Patient on any 
drugs: 
Preoperative  examination: 
     BP:                        PR :               Room air SpO2: 
     CVS :                  RS:                                  CNS:  
Diagnosis:                                   Surgery being performed:                                                                   
Investigations:    
  OBSERVATIONS: 
                 Group A             Group B 
Successful blockade (Block 
sufficient for surgery) 
  
Time required for 
performing the block 
  
Onset of motor/sensory 
blockade 
  
Level of sensory block to 
pin prick 
  
Rescue analgesia   
Complications of the block   
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CONSENT FORM 
“A COMPARATIVE STUDY OF SUBCLAVIAN PERIVASCULAR 
APPROACH WITH PARA SCALENE APPROACH OF 
BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERIES 
USING NERVE STIMULATOR ”, 
Study centre: Department of Anesthesiology, Kilpauk Medical 
College 
Participant name:                                             Age:                    Sex:  
I.P.No: 
I confirm that I have understood the purpose of the procedure for the 
above study. I had the opportunity to ask questions and all questions 
and doubts have been answered to my satisfaction. 
I have been explained about the pitfalls in the procedure and the 
management of it. I have been explained about the safety, advantages 
and disadvantages of the technique. 
I understand that my participation in the study is voluntary and that I 
am free to withdraw at anytime without giving any reason. 
I understand that the investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records 
both in respect to current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study. 
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I understand that my identity will not be revealed in any information 
released to third parties or published, unless as required under the law. 
I agree not to restrict the use of any data or results that arise from the 
study. 
I hereby consent to participate in this study. 
Name of patient:                          Signature/Thumb impression: 
 
Name of witness:                         Signature:  
      Address:                                      Contact number: 
 
Name of investigator:                 Signature:  
Date:  
Place: 
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